去氧氟尿苷|T1600

價格	￥108
包裝	1g

最小起訂量	1g
發(fā)貨地	上海
更新日期	2025-03-12

QQ交談微信洽談

產(chǎn)品詳情

中文名稱:去氧氟尿苷	英文名稱:Doxifluridine
CAS:3094-09-5	品牌: TargetMol
產(chǎn)地: 美國	保存條件: Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice./Shipping at ambient temperature.
純度規(guī)格: 99.47%	產(chǎn)品類別: 抑制劑
貨號: T1600

Product Introduction

Bioactivity

名稱	Doxifluridine
描述	Doxifluridine (AMC 0101) is a fluoropyrimidine derivative and oral prodrug of the antineoplastic agent 5-fluorouracil (5-FU) with antitumor activity. Doxifluridine, designed to circumvent the rapid degradation of 5-FU by dihydropyrimidine dehydrogenase in the gut wall, is converted into 5-FU in the presence of pyrimidine nucleoside phosphorylase. 5-FU interferes with DNA synthesis and subsequent cell division by reducing normal thymidine production and interferes with RNA transcription by competing with uridine triphosphate for incorporation into the RNA strand.
體外活性	Doxifluridine suppresses tube formation of HUVEC and vascular endothelial growth factor production by FU-MMT-1 cells. [1] Doxifluridine is converted to 5-FU and subsequently to FdUMP, and the results suggest that Doxifluridine exerts its cytotoxic effects through inhibition of TS and incorporation into RNA. [2] Doxifluridine is a fluoropyrimidine derivative that is activated preferentially in malignant cells by thymidine phosphorylase to form 5-fluorouracil (5-FU). Doxifluridine is developed to improve the therapeutic index of 5-FU and to reduce toxicity, including the immunosuppressive, myelosuppressive, and cardiotoxic effects of 5-FU and other fluorinated pyrimidines. [3]
體內(nèi)活性	Metronomic Doxifluridine alone significantly suppresses tumor growth compared with the untreated (control) group, while metronomic Doxifluridine in combination with TNP-470 significantly inhibits tumor growth compared with each treatment alone in in FU-MMT-1 xenografts. Doxifluridine in combination with TNP-470 also leads to a significant reduction of intratumoral vascularity. [1] Doxifluridine significantly inhibits the growth of KPL-4 tumors, reduces the tissue levels of IL-6, and alleviates body weight loss in nude mice bearing KPL-4 tumors. [4] Doxifluridine results in a significant reduction in the activity of phenytoin p-hydroxylation in rats. Doxifluridine decreases the elimination rate constant and the total clearance in rats. [5]
存儲條件	Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice./Shipping at ambient temperature.
溶解度	Ethanol : < 1 mg/mL (insoluble or slightly soluble) H2O : 45 mg/mL (182.79 mM), Sonication is recommended. DMSO : 55 mg/mL (223.4 mM), Sonication is recommended.
關(guān)鍵字	Thymidine phosphorylase \| RNASynthesis \| RNA Synthesis \| NucleosideAntimetabolite \| Nucleoside Antimetabolite/Analog \| Nucleoside Antimetabolite \| Inhibitor \| inhibit \| Doxifluridine \| DNASynthesis \| DNA Synthesis \| Analog \| AMC-0101 \| AMC0101
相關(guān)產(chǎn)品	Capecitabine \| Guanidine hydrochloride \| Methotrexate disodium \| Procaine \| Folic acid \| Cisplatin \| 5-Fluorouracil \| Adenine hemisulfate \| Stavudine \| Quinizarin \| Thymidine \| Rifaximin
相關(guān)庫	經(jīng)典已知活性庫 \| 抗癌活性化合物庫 \| 抗癌上市藥物庫 \| 已知活性化合物庫 \| 細(xì)胞周期化合物庫 \| 肝臟毒性化合物庫 \| ReFRAME 相關(guān)化合物庫 \| 含氟化合物庫 \| 抗衰老化合物庫 \| 藥物功能重定位化合物庫 \| 抗癌臨床化合物庫 \| 抗癌藥物庫

關(guān)鍵字：去氧氟尿苷|||Ro 21-9738|||AMC 0101|||5-Fluoro-5'-deoxyuridine|||5'-DFUR|TargetMol

公司簡介

上海陶術(shù)生物科技有限公司為美國Target Molecule Corp. ( Target Mol ) 在上海建立的全資子公司。我們與美國波士頓、德國慕尼黑的同事一起，為北美、歐洲和亞洲從事藥物研發(fā)和生物學(xué)研究的科學(xué)家提供優(yōu)質(zhì)的產(chǎn)品和專業(yè)的服務(wù)。公司下設(shè)篩選事業(yè)部，化學(xué)事業(yè)部，生物事業(yè)部和新材料部。從虛擬篩選到實(shí)體化合物分子供應(yīng)；從商業(yè)化產(chǎn)品銷售到個性化定制合成；從對明確靶點(diǎn)的分子篩選到對明確分子的多靶點(diǎn)篩選，從高通量篩選到化學(xué)結(jié)構(gòu)優(yōu)化，我們都可以滿足您的科研用品及技術(shù)服務(wù)的需求。經(jīng)過在中國市場五年的精心耕耘，我們已成為篩選化合物領(lǐng)域優(yōu)秀的供應(yīng)商，為超過五百家學(xué)校和各類企業(yè)提供了品質(zhì)卓越的小分子化合物和藥物篩

成立日期	2013-04-18 （13年）	注冊資本	566.2651萬人民幣
員工人數(shù)	100-500人	年?duì)I業(yè)額	￥ 1億以上
主營行業(yè)	化學(xué)試劑,生物活性小分子	經(jīng)營模式	貿(mào)易,試劑,定制,服務(wù)

TargetMol中國（陶術(shù)生物）

VIP 13年

公司成立：13年
注冊資本：566.2651萬人民幣
企業(yè)類型：有限責(zé)任公司(自然人投資或控股)
主營產(chǎn)品：小分子抑制劑，藥物篩選化合物庫，天然產(chǎn)物，活性分子化合物等
公司地址：上海市閘北區(qū)江場三路28號4樓

進(jìn)入店鋪

詢盤

店內(nèi)推薦

氟氯西林鈉|T5006

￥125

熒光素鈉|T4065

￥587

羅哌卡因|T0386L

￥678